The differences in Aβ42, tau, p-tau-181, and p-tau-S396 levels in plasma neuron-derived EVs among control individuals, those with MCI, and those with AD were strongly correlated with CSF levels, and the diagnostic efficacy of these combined markers in EVs was comparable to that of CSF. This evidence concerns the gene MAPT and Alzheimer disease.